Abstract Pre-eclampsia is a disorder that aVects approximately 5% of pregnancies. We tested the hypothesis that skewed X-chromosome inactivation (XCI) could be involved in the pathogenesis of preeclampsia. Peripheral blood DNA was obtained from 67 pre-eclampsia patients and 130 control women. Androgen receptor (AR) was analyzed by the HpaII/ polymerase chain reaction assay to assess XCI patterns in DNA extracted from peripheral-blood cells. In addition, buccal cells were obtained from seven patients, and the analysis repeated. Extremely skewed XCI was observed in 10 of 46 informative patients (21.74%), and in 2 of 86 informative controls (2.33%, P = 0.0005; 2 test). Our Wndings support a role for the X-chromosome in the pathogenesis of pre-eclampsia in a subgroup of patients.
Introduction
Pre-eclampsia is a pregnancy-speciWc syndrome of unknown etiology. It is the leading cause of maternal and perinatal mortality, characterized by increased blood pressure and proteinuria (Roberts and Cooper 2001; Broughton Pipkin 2001) . The disease occurs only in the presence of a placenta and resolves with the removal of the placenta. Studies that aim to identify susceptibility loci with signiWcant linkage to familial cases of pre-eclampsia (OMIM 189800) resulted in the identiWcation of four chromosome regions: 2p13 (Iceland) (Arngrimsson et al. 1999 ), 2p25 and 9p13 (Finland) (Laivuori et al. 2003) , and 10q22 (The Netherlands) (Lachmeijer et al. 2001; Oudejans et al. 2004 ). The Dutch pre-eclampsia locus shows maternal segregation, and recently STOX1 (storkhead box 1; also called C10orf24), was identiWed as a candidate gene for this locus (van Dijk et al. 2005) .
Maternal endothelial dysfunction and failure of the tolerance system as evidenced by Th-1 type immunity are early pathophysiological modiWcations in preeclampsia (Saito and Sakai 2003) . Failure of the tolerance system is associated with autoimmune diseases. A negative selection system against potentially self-reactive T-cells in the thymic medulla and cortex-medulla junction is critically important in establishing T-cell tolerance. The negative selection process is mediated primarily by the dendritic cells, which participate in antigen presentation (Speiser et al. 1989; Laufer et al. 1996) . Lack of exposure to self-antigens in the thymus and the presence of autoreactive T-cells have been shown to increase the risk of autoimmunity (Klein et al. 2000) .
It was hypothesized that disturbed X-chromosome inactivation (XCI) could be a mechanism whereby lack of exposure to self-antigens may occur in females (Kast 1977; Stewart 1998) . X-inactivation is an epigenetic modiWcation in females that results in the transcriptional inactivation of one of the pair of X-chromosomes at random (Lyon 1961) . Normal females are thus mosaics of two cell populations. Four recently published studies, one by a Japanese group on primary ovarian failure (Sato et al. 2004) , one by us on scleroderma (Ozbalkan et al. 2005) , and two on autoimmune thyroid diseases (Brix et al. 2005; Ozcelik et al. 2006) , raised the possibility that skewed XCI could play an important role in the pathogenesis of autoimmune diseases. Since the disease may have an autoimmune component, we hypothesized that skewed XCI could be involved in the pathogenesis of pre-eclampsia as well.
We observed that the number of women with extreme skewing of XCI is signiWcantly higher in the pre-eclampsia group than in healthy control women with no history of pre-eclampsia, autoimmune diseases or cancer. The cause of skewed XCI mosaicism in autoimmune diseases and pre-eclampsia is not yet known. Possible mechanisms include skewing of XCI as cause of the disease, or alternatively the cause of pre-eclampsia could also be the cause of the skewing.
Materials and methods

Patients
Sixty-seven Caucasian women diagnosed with preeclampsia, and 130 apparently healthy Caucasian female controls were genotyped to determine whether women with pre-eclampsia have a greater frequency of extremely skewed XCI than control subjects. The ethics review board of the participating institutions approved study protocol. Pregnancy history, age, and disease information accompanied by informed consent was obtained from all subjects. In the control group (124/130) women gave birth to at least one child, and none had a history of pregnancy loss, autoimmune disease or cancer. The birth registry at the Etlik Maternity and Women's Health Teaching Hospital in Ankara was used to contact the pre-eclamptic cases. All women in the patient group had singleton deliveries. The mean ages were 29.8 § 5.7 years (mean § SD; range = 21-42 years old) for the cases, and 31.6 § 5.6 (range = 21-47 years old) for the controls.
Pre-eclampsia was deWned as the development of hypertension plus proteinuria within 7 days of each other after the twentieth week of gestation in women with no proteinuria at baseline. Hypertension and severe hypertension were deWned as diastolic blood pressures of at least 90 and 110 mm Hg, respectively, occurring on at least two occasions, 4-168 h apart. Urinary protein excretion of >300 mg in 24 h was indicative of proteinuria. Pre-eclampsia was considered severe in the presence of severe hypertension or severe proteinuria, HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), or eclampsia. Those subjects with a previous history of chronic hypertension, renal disease or diabetes mellitus were excluded.
X-chromosome inactivation analysis DNA was extracted from 10 ml venous blood samples with NucleoSpin Blood kit (Macherey-Nagel, Düren, Germany) according to the manufacturer's protocol. After ethanol precipitation, DNA was dissolved in distilled water and stored at 4°C.
Genotyping of a highly polymorphic CAG repeat in the androgen-receptor (AR) gene was performed to assess the XCI patterns (Allen et al. 1992) . Patients with ¸90% representation of one allele were classiWed as extremely skewed XCI. The DNA was divided into two identical aliquots, one of which was incubated overnight at 37°C with methylation-sensitive restriction enzyme HpaII (MBI Fermentas, Vilnius, Lithuania) for the digestion of unmethylated (or active) alleles. A second restriction enzyme, RsaI (MBI Fermentas, Vilnius, Lithuania), which recognizes a four base pair sequence not present in the ampliWed region of the AR locus was also included in the reaction to facilitate the HpaII digestion process. The other aliquot of the DNA was digested with RsaI alone as a control. Male DNA with cytogenetically veriWed 46XY karyotype was used as a control for incomplete digestion.
After restriction enzyme digest, residual DNA was ampliWed by using the primers 5Ј-GTC CAA GAC CTA CCG AGG AG-3Ј and 5Ј-CCA GGA CCA GGT AGC CTG TG-3Ј. Amplicons were labeled by including a radioactive nucleotide ( -[ 33 P] -dCTP) (NEN, Perkin Elmer Life Sciences, Boston, Massachusetts) in the polymerase chain reaction (PCR). PCR products were separated on 8% denaturing 29:1 acrylamide/bisacrylamide gel for 5 h at 60 W. Gels were dried and autoradiographed on MedicalWlm CP-BU (Agfa, AgfaGevaert AG, Belgium). Densitometric analysis of the alleles was performed at least twice for each sample using the appropriate software (MultiAnalyst version 1.1; Bio-Rad, Hercules, California).
In addition, cold PCR followed by electrophoretic separation of the alleles in 4% MetaPhor agarose (FMC BioProducts, Rockland, Maine) for 4 h 30 min at 80 V was carried out. Since the number of cycles could be critically important for the outcome of densitometric analyses, samples were subjected to 25 and also 30 cycles of ampliWcation during the hot and the cold PCR. Products were visualized by ethidium bromide staining, and densitometric analysis of the alleles was performed at least twice for each sample using the MultiAnalyst version 1.1software. A corrected ratio (CrR) was calculated by dividing the ratio of the predigested sample (upper/lower allele) by the ratio of the non-predigested sample for normalization of the ratios that were obtained from the densitometric analyses. The use of CrR compensates for preferential ampliWcation of the shorter allele when the number of PCR cycles increases (Delforge et al. 1995) . A skewed population is deWned as a cell population with greater than 80% expression of one of the AR alleles. This corresponds to CrR values of <0.33 or >3.
Statistical methods
The results from control and test groups were compared by the Fisher's exact test.
Results
XCI status was found to be informative in 69% of the cases (46/67) and 66% of the controls (86/130). Only those individuals whose alleles resolve adequately for densitometric analysis were included in the study. Extremely skewed XCI was present in ten (21.74%) cases and two (2.33%) controls (P = 0.0005). It is well established that extremely skewed XCI is a rare event in a diverse group of control females (Busque et al. 1996; Naumova et al. 1996; Sharp et al. 2000; AmosLandgraf et al. 2006) . When XCI values between 80 and 89% were also considered, skewed XCI was observed in 16 of the 46 (34.78%) informative cases, and 8 of the 86 (9.30%) controls (P = 0.0006) ( Table 1) . DNA from buccal cells was analyzed in seven patients with various degrees of skewing. They were chosen randomly to assess whether the results from blood, a mesodermal tissue, is comparable to other tissue types such as buccal cells, which have an ectodermal origin. Similar XCI patterns were observed (Table 2) . Since it would be of interest to identify diVerences in the pregnancy details between those of women with extreme skewing, and women with normal X-inactivation, we obtained clinical characteristics of the pre-eclampsia patients informative for XCI status, and the controls (Supplemental Tables 1, 2) . Although the numbers are too small to reach a conclusion, it is interesting that recurrent spontaneous abortions is three times more common in women with extreme skewing (3/10) than in women with random patterns of XCI (3/30) (Supplemental Table 3 ). It is well established that the frequency of skewed XCI is increased in recurrent spontaneous abortions (Lanasa et al. 1999; Sangha et al. 1999; Bagislar et al. 2006) . Interestingly, a common genetic background for pre-eclampsia and recurrent spontaneous abortions has been questioned in the medical literature (Christiansen et al. 1990 ).
Discussion
We observed skewed XCI patterns in peripheral-blood mononuclear cells of a signiWcant proportion (35%) of females with pre-eclampsia. Approximately 9% of female control subjects demonstrated skewed XCI patterns ¸80:20. The eVect is also pronounced at patterns of XCI ¸90:10; nearly a quarter of pre-eclampsia patients showed such skewing, compared with only 2% of control subjects. Although skewed XCI patternş 80:20 could be as high as 19.5% (Amos-Landgraf et al. 2006) or 21.6% (Naumova et al. 1996) in phenotypically normal females, skewing in the range of 90:10 or ¸95:5 is quite rare with only 3.6 and 1.7% of the population, respectively (Amos-Landgraf et al. 2006) . With respect to the relatively low percentage of controls in the ¸80:20 range in our study, this result may be a reXection of the pregnancy histories. An overwhelming majority (124/130) had experienced a normal pregnancy period with healthy deliveries.
Clinical manifestation of X-linked disorders in females could be inXuenced as a consequence of disturbances in the XCI process (Lyon 2002) . High frequency of skewed XCI has also been observed in recurrent spontaneous abortions (Lanasa et al. 1999; Sangha et al. 1999 ), X-linked mental retardation (Plenge et al. 2002) , breast and ovarian cancers (Kristiansen et al. 2002) , and in mothers of homosexual men (Bocklandt et al. 2006 ). In addition, it has been hypothesized that skewed XCI could be a factor that inXuences female predisposition to autoimmunity: recently skewed XCI has been reported in three autoimmune disorders, scleroderma (Ozbalkan et al. 2005) , autoimmune thyroid diseases (Brix et al. 2005; Ozcelik et al. 2006) , and premature ovarian failure (Sato et al 2004) . Skewed XCI could be the result of a bias in the initial choice of which X-chromosome is inactivated (primary cause), or selection against cells in which a given X-chromosome has been inactivated (secondary cause) [for review see Puck and Willard 1998; Brown 1999] . At present, we do not know the nature of the relationship between XCI patterns and pre-eclampsia; except that aging (a secondary cause) is highly unlikely to be involved because of the relatively young ages of the patients (mean age of diagnosis at 29.8 § 5.7 years for all the patients, 30.3 § 6.2 years for patients with skewed XCI, and 29.4 § 5.5 years for patients with random XCI) (Fig. 1) . However, two possibilities could be considered: The cause of pre-eclampsia could also be the cause of the skewing, or the skewing of XCI could be the cause of pre-eclampsia. If the autoimmune reaction is the cause of the secondary selection, the disease would cause the skewing. Alternatively, if the disease is at least partially caused by an X-chromosome gene, the disease allele could increase or decrease the Wtness of cells inactivating the wild type or mutant allele of this gene, leading to secondary selection for immune cells inactivating one or both X-chromosomes. This would mean that the X-linked gene causes both the disease and the skewing. Since both, pre-eclampsia and skewed XCI may be heritable traits, the women with preeclampsia and skewed XCI may share the same mutation(s) in one or more X-linked genes. This implies that it would be particularly important to establish if any of the women who are included in the study were related. However, they were neither related, nor were they from the same geographical location.
Skewed XCI patterns are now demonstrated in a signiWcant proportion of a subgroup of pre-eclampsia patients. Therefore, disturbed XCI mosaicism could be considered as a contributing factor to disease pathogenesis. Further studies, such as haplotype analysis of X-linked markers in mother-child pairs of pre-eclampsia patients, and a search for X-chromosomal aberrations in pre-eclampsia patients by microarray analysis (Larrabee et al. 2004) , could be critically important in understanding the genetic etiology.
